-
Je něco špatně v tomto záznamu ?
Frentizole derivatives with mTOR inhibiting and senomorphic properties
Z. Chrienova, D. Rysanek, J. Novak, P. Vasicova, P. Oleksak, R. Andrys, A. Skarka, J. Dumanovic, Z. Milovanovic, V. Jacevic, M. Chvojkova, K. Holubova, K. Vales, V. Skoupilova, M. Valko, K. Jomova, SY. Alomar, FD. Botelho, TCC. Franca, K. Kuca,...
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2018
Elsevier Open Access Journals
od 2018-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2002
- MeSH
- Alzheimerova nemoc * MeSH
- amyloidní beta-protein * metabolismus MeSH
- imunosupresiva MeSH
- léky proti stárnutí MeSH
- myši MeSH
- sirolimus MeSH
- TOR serin-threoninkinasy MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Frentizole is immunosuppressive drug with low acute toxicity and lifespan-prolonging effect. Recently, frentizole ́s potential to disrupt toxic amyloid β (Aβ) - Aβ-binding alcohol dehydrogenase (ABAD) interaction in mitochondria in Alzheimer ́s brains has been revealed. Another broadly studied drug with anti-aging and immunosuppressive properties is an mTOR inhibitor - rapamycin. Since we do not yet precisely know what is behind the lifespan-prolonging effect of rapamycin and frentizole, whether it is the ability to inhibit the mTOR signaling pathway, reduction in mitochondrial toxicity, immunosuppressive effect, or a combination of all of them, we have decided within our previous work to dock the entire in-house library of almost 240 Aβ-ABAD modulators into the FKBP-rapamycin-binding (FRB) domain of mTOR in order to interlink mTOR-centric and mitochondrial free radical-centric theories of aging and thus to increase the chances of success. Based on the results of the docking study, molecular dynamic simulation and MM-PBSA calculations, we have selected nine frentizole-like compounds (1 - 9). Subsequently, we have determined their real physical-chemical properties (logP, logD, pKa and solubility in water and buffer), cytotoxic/cytostatic, mTOR inhibitory, and in vitro anti-senescence (senolytic and senomorphic) effects. Finally, the three best candidates (4, 8, and 9) have been forwarded for in vivo safety studies to assess their acute toxicity and pharmacokinetic properties. Based on obtained results, only compound 4 demonstrated the best results within in vitro testing, the ability to cross the blood-brain barrier and the lowest acute toxicity (LD50 in male mice 559 mg/kg; LD50 in female mice 575 mg/kg).
3rd Faculty of Medicine Charles University Ruska 87 100 00 Prague 10 Czech Republic
Faculty of Chemistry University of Belgrade Studenski trg 16 11000 Belgrade Serbia
National Institute of Mental Health Topolova 748 250 67 Klecany Czech Republic
Special Police Unit Ministry of Interior Trebevićka 12 A 11030 Belgrade Serbia
Zoology Department College of Science King Saud University Riyadh 11451 Saudi Arabia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000825
- 003
- CZ-PrNML
- 005
- 20240213093407.0
- 007
- ta
- 008
- 240109e20230930fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biopha.2023.115600 $2 doi
- 035 __
- $a (PubMed)37783152
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Chrienova, Zofia $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic
- 245 10
- $a Frentizole derivatives with mTOR inhibiting and senomorphic properties / $c Z. Chrienova, D. Rysanek, J. Novak, P. Vasicova, P. Oleksak, R. Andrys, A. Skarka, J. Dumanovic, Z. Milovanovic, V. Jacevic, M. Chvojkova, K. Holubova, K. Vales, V. Skoupilova, M. Valko, K. Jomova, SY. Alomar, FD. Botelho, TCC. Franca, K. Kuca, Z. Hodny, E. Nepovimova
- 520 9_
- $a Frentizole is immunosuppressive drug with low acute toxicity and lifespan-prolonging effect. Recently, frentizole ́s potential to disrupt toxic amyloid β (Aβ) - Aβ-binding alcohol dehydrogenase (ABAD) interaction in mitochondria in Alzheimer ́s brains has been revealed. Another broadly studied drug with anti-aging and immunosuppressive properties is an mTOR inhibitor - rapamycin. Since we do not yet precisely know what is behind the lifespan-prolonging effect of rapamycin and frentizole, whether it is the ability to inhibit the mTOR signaling pathway, reduction in mitochondrial toxicity, immunosuppressive effect, or a combination of all of them, we have decided within our previous work to dock the entire in-house library of almost 240 Aβ-ABAD modulators into the FKBP-rapamycin-binding (FRB) domain of mTOR in order to interlink mTOR-centric and mitochondrial free radical-centric theories of aging and thus to increase the chances of success. Based on the results of the docking study, molecular dynamic simulation and MM-PBSA calculations, we have selected nine frentizole-like compounds (1 - 9). Subsequently, we have determined their real physical-chemical properties (logP, logD, pKa and solubility in water and buffer), cytotoxic/cytostatic, mTOR inhibitory, and in vitro anti-senescence (senolytic and senomorphic) effects. Finally, the three best candidates (4, 8, and 9) have been forwarded for in vivo safety studies to assess their acute toxicity and pharmacokinetic properties. Based on obtained results, only compound 4 demonstrated the best results within in vitro testing, the ability to cross the blood-brain barrier and the lowest acute toxicity (LD50 in male mice 559 mg/kg; LD50 in female mice 575 mg/kg).
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 _2
- $a léky proti stárnutí $7 D000089322
- 650 _2
- $a imunosupresiva $7 D007166
- 650 _2
- $a sirolimus $7 D020123
- 650 _2
- $a TOR serin-threoninkinasy $7 D058570
- 650 12
- $a Alzheimerova nemoc $7 D000544
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rysanek, David $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic
- 700 1_
- $a Novak, Josef $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic
- 700 1_
- $a Vasicova, Pavla $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic
- 700 1_
- $a Oleksak, Patrik $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Andrys, Rudolf $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Skarka, Adam $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Dumanovic, Jelena $u Faculty of Chemistry, University of Belgrade, Studenski trg 16, 11000 Belgrade, Serbia
- 700 1_
- $a Milovanovic, Zoran $u Special Police Unit, Ministry of Interior, Trebevićka 12/A, 11030 Belgrade, Serbia
- 700 1_
- $a Jacevic, Vesna $u Department of Experimental Toxicology and Pharmacology, National Poison Control Centre, Military Medical Academy & Medical Faculty of the Military Medical Academy, University of Defence, 11 Crnotravska, 11000 Belgrade, Serbia
- 700 1_
- $a Chvojkova, Marketa $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic; National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic
- 700 1_
- $a Holubova, Kristina $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic; National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic
- 700 1_
- $a Vales, Karel $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic; National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic; Third Faculty of Medicine, Charles University, Ruska 87, 100 00 Prague 10, Czech Republic
- 700 1_
- $a Skoupilova, Veronika $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Valko, Marian $u Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, 812 37 Bratislava, Slovakia
- 700 1_
- $a Jomova, Klaudia $u Department of Chemistry, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, 949 01 Nitra, Slovakia
- 700 1_
- $a Alomar, Suliman Y $u Zoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
- 700 1_
- $a Botelho, Fernanda D $u Laboratory of Molecular Modeling Applied to Chemical and Biological Defense (LMCBD), Military Institute of Engineering, 22290-270 Rio de Janeiro, RJ, Brazil
- 700 1_
- $a Franca, Tanos C C $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic; Laboratory of Molecular Modeling Applied to Chemical and Biological Defense (LMCBD), Military Institute of Engineering, 22290-270 Rio de Janeiro, RJ, Brazil
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Hodny, Zdenek $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic. Electronic address: zdenek.hodny@img.cas.cz
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. Electronic address: eugenie.nepovimova@uhk.cz
- 773 0_
- $w MED00005486 $t Biomedicine & pharmacotherapy $x 1950-6007 $g Roč. 167 (20230930), s. 115600
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37783152 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093404 $b ABA008
- 999 __
- $a ok $b bmc $g 2049435 $s 1210519
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 167 $c - $d 115600 $e 20230930 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
- LZP __
- $a Pubmed-20240109